BioCentury
ARTICLE | Company News

Management tracks

June 19, 2015 1:19 AM UTC

Gene therapy company AveXis Inc. (Dallas, Texas) hired Sean Nolan as CEO. He replaces John Carbona, who resigned in April. Nolan was CBO at InterMune Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired.

Ophthalmic company Envisia Therapeutics Inc. (Research Triangle Park, N.C.) named Eric Linsley CFO. Linsley was a managing partner at Pappas Ventures. ...